From Medscape Neurology

Medscape Medical News from the:

American Academy of Neurology (AAN) 64th Annual Meeting

April 21 - 28, 2012; New Orleans, Louisiana

This coverage is not sanctioned by, nor a part of, the American Academy of Neurology.

Meeting Highlights at a Glance

Top News From AAN 2012: Slideshow
Among the highlights: a new guideline for the prevention of episodic migraine, more positive results with BG-12 for MS, and IMS 3 stroke trial halted.


Conference News

Medscape Neurology©  WebMD, LLC

Perspectives

The Evolution of Medical Publishing
Andrew N. Wilner, MD;
Diana M. Schneider, PhD

What Causes Parkinson Disease?
Bret Stetka, MD;
Caroline M. Tanner, MD, PhD

Diffusion Tensor Imaging: A New Window Into Mild TBI
Andrew N. Wilner, MD;
Christine MacDonald, PhD

A Glimpse Into Medical Reporting
Andrew N. Wilner, MD;
Orly Avitzur, MD, MBA

IOM Report: Public Health Dimensions of the Epilepsies
Andrew N. Wilner, MD;
José E. Cavazos, MD, PhD

Upping the Dose in Alzheimer's?
Jeffrey Cummings, MD


Biomarkers and Biopsies: The New Neurology Toolkit?
Bret Stetka, MD;
José G. Merino, MD, MPhil

Four Experts, 4 Opinions in Treating MS?
Andrew N. Wilner, MD;
Mark S. Freedman, MD

Six Years in the Making: New Episodic Migraine Guidelines
Andrew N. Wilner, MD;
David W. Dodick, MD

A Giant Step for Epilepsy
Andrew N. Wilner, MD



Four Upcoming Breakthroughs in Neurology?
Bret Stetka, MD;
José G. Merino, MD, MPhil

Three Important Findings in Alzheimer Disease
Jeffrey Cummings, MD


A New Era in MS Therapy
Andrew N. Wilner, MD;
Mark S. Freedman, MD


New Orleans Dining Guide

AAN 2012: A New Orleans Dining Guide
Bret S. Stetka, MD